Evidence map›Paper›PMID 41735045›Full record

Trial reportPrimary health care research & development2026

Free cessation aids and enhanced support for smoking cessation in disadvantaged smokers: a qualitative study of patient and provider insights.

Paloma Vera, Maria Melchior, Djylal Badreddine, Marie-Noel Al Zayat, Gladys Ibanez, Melanie Böckmann, Fabienne El-Khoury

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Primary health care research & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paloma VeraSorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Healthhttps://ror.org/02en5vm52, IPLESP, Social Epidemiology, Mental Health and Addictions, ESSMA, F75012, Paris, France.
Maria MelchiorSorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Healthhttps://ror.org/02en5vm52, IPLESP, Social Epidemiology, Mental Health and Addictions, ESSMA, F75012, Paris, France.
Djylal BadreddineSorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Healthhttps://ror.org/02en5vm52, IPLESP, Social Epidemiology, Mental Health and Addictions, ESSMA, F75012, Paris, France.
Marie-Noel Al ZayatSorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Healthhttps://ror.org/02en5vm52, IPLESP, Social Epidemiology, Mental Health and Addictions, ESSMA, F75012, Paris, France.ORCID 0009-0008-5929-1136
Gladys IbanezSorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Healthhttps://ror.org/02en5vm52, IPLESP, Social Epidemiology, Mental Health and Addictions, ESSMA, F75012, Paris, France.
Melanie BöckmannUniversity of Bremen: Universitat Bremen, Germany.ORCID 0000-0001-5909-5508
Fabienne El-KhourySorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Healthhttps://ror.org/02en5vm52, IPLESP, Social Epidemiology, Mental Health and Addictions, ESSMA, F75012, Paris, France.ORCID 0000-0002-6915-6850

Funding

Non-US Government Research Support type
6 · The paper itself

Abstract

aimTo explore facilitators and barriers to smoking cessation among smokers experiencing socioeconomic disadvantage, from the perspectives of patients and healthcare providers (HP) participating in the STOP randomized controlled trial (STOP-RCT).

backgroundSmoking remains disproportionately prevalent among socioeconomically disadvantaged individuals, contributing to significant health disparities. The STOP-RCT evaluates a preference-based smoking cessation intervention offering free nicotine replacement therapy (NRT) and e-cigarettes to disadvantaged smokers.

methodsA qualitative study was conducted involving semi-structured interviews with 14 participants and 5 HP from the STOP-RCT. Data collection explored participants' smoking cessation experiences, perceptions of the intervention, the quitting process, and the factors that influence cessation. Thematic analysis was used to analyse the transcribed data. Themes were categorized into structural and individual factors, refined iteratively, and supported by illustrative quotes.

findingsFour key facilitators were identified: (1) longer consultations enabling tailored support; (2) regular follow-up promoting patient engagement; (3) immediate and free access to NRT and carbon monoxide (CO) monitoring, reducing financial and practical barriers while providing feedback; and (4) shared decision-making, strengthening trust and improving the fit of support. These findings highlight the importance of addressing both treatment approach (contextual) and interpersonal factors for this population. Considering these elements may help adapt cessation programmes to the specific difficulties and needs of patients with low socioeconomic position, thereby reinforcing treatment adherence and improving effectiveness.

Indexed as

Health PersonnelSmokersSmoking CessationTobacco Use Cessation DevicesVulnerable PopulationsAdultFemaleHumansInterviews as TopicMaleMiddle AgedNicotine Replacement TherapyQualitative ResearchNicotine replacement therapyprofessional-patient relationsshared decision-makingsmoking cessationvulnerable populations

Identifiers

PMID41735045
PMCPMC12951339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.